Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins
- 27 December 2016
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (2) , 376-381
Abstract
Significance: Multiple myeloma (MM) cells are highly dependent on signals provided by the bone marrow (BM) niche for growth and survival. Most MMs display hallmarks of active Wnt signaling, but lack activating Wnt-pathway mutations, suggesting activation by autocrine Wnt ligands and/or paracrine Wnts emanating from the BM niche. In this study we uncover a pivotal role for the leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4)/R-spondin axis in facilitating activation of Wnt signaling in MM. LGR4 is expressed by most MMs, but not by healthy plasma cells, and is regulated by STAT3 signaling. LGR4 expression allows MMs to respond to (pre)osteoblast–derived R-spondins, resulting in stabilization of Wnt receptors and greatly enhanced sensitivity to auto- and paracrine Wnt ligands. These results advocate targeting of proximal Wnt signaling in MM.Keywords
Funding Information
- KWF Kankerbestrijding (UVA 2011-5205)
- European commision (FP7 OVER-MyR)
This publication has 62 references indexed in Scilit:
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted TherapyCancer Cell, 2014
- Decoding the Pathophysiology and the Genetics of Multiple Myeloma to Identify New Therapeutic TargetsSeminars in Oncology, 2013
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- The genetic architecture of multiple myelomaNature Reviews Cancer, 2012
- Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple MyelomaPLOS ONE, 2012
- Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progressionBlood, 2009
- β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse ModelClinical Cancer Research, 2009
- Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targetsNature Reviews Cancer, 2007
- Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myelomaProceedings of the National Academy of Sciences, 2007
- Illegitimate WNT signaling promotes proliferation of multiple myeloma cellsProceedings of the National Academy of Sciences, 2004